Yarrow Bioscience, Inc. (Nasdaq: YARW) has completed its merger with VYNE Therapeutics Inc. and closed private financings totaling approximately $200 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE